3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
22
Breast Neoplasms
18
Hematologic Neoplasms
16
Colorectal Neoplasms
13
Prostatic Neoplasms
11
Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pancreatic Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
9
Anatomic Stage I Breast Cancer AJCC v8
9
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Multiple Myeloma
5
Leukemia, Myeloid, Acute
5
Head and Neck Carcinoma
5
Breast Carcinoma In Situ
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Melanoma
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Neoplasms
4
Carcinoma, Renal Cell
4
Rectal Neoplasms
3
Myelodysplastic Syndromes
3
Mouth Neoplasms
3
Malignant Solid Neoplasm
3
Lymphoma
3
Interventions
Gemcitabine
13
pembrolizumab
9
Specimen Handling
9
enfortumab vedotin
8
Cisplatin
8
Magnetic Resonance Spectroscopy
7
avelumab
5
Carboplatin
5
vinflunine
4
Nivolumab
4
atezolizumab
3
Immunoglobulin G
3
Disulfides
3
Biopsy
3
eribulin
2
cabozantinib
2
Standard of Care
2
Ramucirumab
2
Radiotherapy
2
Platinum
2
Nephroureterectomy
2
Ipilimumab
2
Doxorubicin
2
Docetaxel
2
CTLA-4 Antigen
2
Bortezomib
2
1,2-diaminocyclohexaneplatinum II citrate
2
vandetanib
1
tremelimumab
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Ureteral Neoplasms
×
Practice Guidelines as Topic
×
Clear all
NCT07087860
2026-05-08
RECIPE-B1
Mayo Clinic
Phase 2
Recruiting
70 enrolled